FADUMO OSMAN: Open Payments
NPI 1417639378 · HILLIARD, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$625 in 21 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $251 · 2025 $625
Food & beverage: $625
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 8 | $240 |
| Neurocrine BioSciences, Inc. | 1 | $129 |
| E.R. Squibb & Sons, L.L.C. | 3 | $82 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $78 |
| Alkermes, Inc. | 2 | $35 |
| Indivior Inc. | 1 | $32 |
| Janssen Pharmaceuticals, Inc | 1 | $15 |
| ABBVIE INC. | 1 | $14 |
Products named: HETLIOZ, INGREZZA, FANAPT, COBENFY, CAPLYTA, ARISTADA, SUBLOCADE, INVEGA SUSTENNA.
Industry payments across OH — which companies pay providers there.
